2023

A successful topical treatment for cutaneous inflammatory diseases: an additional or alternative therapy to topical steroids

A. Tammaro tammaroantonella@gmail.com ¹, F. Magri¹, C. Chello¹, D. Giordano¹, F.R. Parisella², G. De Marco¹, S. Persechino¹

Vol. 51 (No. 3) 2019 May

Letter to the Editor

doi: 10.23822/EurAnnACI.1764-1489.79

Show more: Authors information and Publication history

Authors Information

¹Dermatology Unit, NESMOS Department, S. Andrea Hospital, University of Rome "Sapienza", Rome, Italy ²University of Queensland, Brisbane, Australia

History

Published online: 11 April 2019
Accepted: 10 December 2018
Received: 27 July 2018

Full text PDF

Table of Content: Vol. 51 (No. 3) 2019 May

Letter to the Editor

When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation

D. Bagnasco diego.bagnasco@dimi.unige.it¹, T. Aloè¹, F. Sclifò², M.G. Ferrantino³, F. Marugo⁴, F. Arcadipane³, A. Manfredi¹, G.W. Canonica⁵, G. Passalacqua¹

doi: 10.23822/EurAnnACI.1764-1489.88

Download PDF

Letter to the Editor

Methylchloroisothiazolinone / methylisothiazolinone: epidemiological retrospective study

A.I. Lorente-Lavirgen ariselae84@gmail.com ¹, C. Almeida², J. Bernabeu¹, V. Valero³, R. Lorente³

doi: 10.23822/EurAnnACI.1764-1489.92

Download PDF

Letter to the Editor